» Articles » PMID: 16023598

Induction of Apoptosis by an Inhibitor of the Mitotic Kinesin KSP Requires Both Activation of the Spindle Assembly Checkpoint and Mitotic Slippage

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2005 Jul 19
PMID 16023598
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The inhibition of KSP causes mitotic arrest by activating the spindle assembly checkpoint. While transient inhibition of KSP leads to reversible mitotic arrest, prolonged exposure to a KSP inhibitor induces apoptosis. Induction of apoptosis by the KSP inhibitor couples with mitotic slippage. Slippage-refractory cells show resistance to KSP inhibitor-mediated lethality, whereas promotion of slippage after mitotic arrest enhances apoptosis. However, attenuation of the spindle checkpoint confers resistance to KSP inhibitor-induced apoptosis. Furthermore, sustained KSP inhibition activates the proapoptotic protein, Bax, and both activation of the spindle checkpoint and subsequent mitotic slippage are required for Bax activation. These studies indicate that in response to KSP inhibition, activation of the spindle checkpoint followed by mitotic slippage initiates apoptosis by activating Bax.

Citing Articles

Kinesins regulate the heterogeneity in centrosome clustering after whole-genome duplication.

Lau T, Ma H, Poon R Life Sci Alliance. 2024; 7(10).

PMID: 39074902 PMC: 11287020. DOI: 10.26508/lsa.202402670.


Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy.

Liu H, Zhang H, Han Y, Hu Y, Geng Z, Su J Theranostics. 2022; 12(15):6576-6594.

PMID: 36185613 PMC: 9516228. DOI: 10.7150/thno.78034.


Extracting functional insights from loss-of-function screens using deep link prediction.

Strybol P, Larmuseau M, de Schaetzen van Brienen L, Van den Bulcke T, Marchal K Cell Rep Methods. 2022; 2(2):100171.

PMID: 35474966 PMC: 9017186. DOI: 10.1016/j.crmeth.2022.100171.


Computational Study on E-Hooks of Tubulins in the Binding Process with Kinesin.

Xie Y, Li L Int J Mol Sci. 2022; 23(4).

PMID: 35216151 PMC: 8877516. DOI: 10.3390/ijms23042035.


Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.

Pan D, Kaufman J, Htut M, Agrawal M, Mazumder A, Cornell R Cancer Med. 2021; 11(2):358-370.

PMID: 34921527 PMC: 8729045. DOI: 10.1002/cam4.4451.